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Studies in transgenic mice revealed that neurodegenera-
tion induced by scrapie prion (PrPSc) propagation is de-
pendent on neuronal expression of the cellular prion
protein PrPC. On the other hand, there is evidence that
PrPC itself has a stress-protective activity. Here, we show
that the toxic activity of PrPSc and the protective activity of
PrPC are interconnected. With a novel co-cultivation assay,
we demonstrate that PrPSc can induce apoptotic signalling
in PrPC-expressing cells. However, cells expressing PrP
mutants with an impaired stress-protective activity were
resistant to PrPSc-induced toxicity. We also show that the
internal hydrophobic domain promotes dimer formation of
PrP and that dimerization of PrP is linked to its stress-
protective activity. PrP mutants defective in dimer forma-
tion did not confer enhanced stress tolerance. Moreover, in
chronically scrapie-infected neuroblastoma cells the
amount of PrPC dimers inversely correlated with the
amount of PrPSc and the resistance of the cells to various
stress conditions. Our results provide new insight into the
mechanism of PrPC-mediated neuroprotection and indi-
cate that pathological PrP conformers abuse PrPC-depen-
dent pathways for apoptotic signalling.
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Introduction
Prion diseases in humans and other mammals are neurode-
generative diseases characterized by the accumulation of an
abnormally folded prion protein, designated PrPSc, which is
the essential constituent of infectious prions. PrPSc is a self-
propagating isoform of the cellular prion protein (PrPC) with
distinct biochemical and biophysical properties, such as a
high content in b-sheet structures, insolubility in detergent
buffers and increased resistance to proteolytic digestion
(reveiwed in Weissmann et al, 1996; Prusiner et al, 1998;
Collinge, 2001; Chesebro, 2003; Aguzzi and Polymenidou,
2004). PrPC is essential for the pathogenesis of prion diseases.
Mice with a targeted disruption of the PrP gene (PRNP) are
resistant to prion diseases and to the propagation of infec-
tious prions (Büeler et al, 1993). Moreover, neuronal expres-
sion of PrPC seems to be required to mediate neurotoxic
effects of scrapie prion propagation. The first indication for
such a role of PrPC emerged from elegant grafting experi-
ments (Brandner et al, 1996), a finding later supported by a
conditional cell-type-specific PrP knockout mouse model
(Mallucci et al, 2003) and transgenic mice expressing
PrPDGPI, an anchorless PrP mutant (Chesebro et al, 2005).
Moreover, different mouse models revealed that PrP can
acquire a neurotoxic potential in the absence of PrPSc/prion
propagation (reviewed in Winklhofer et al, 2008). One class
of such toxic PrP mutants is characterized by a deleted
internal hydrophobic domain (HD) (Shmerling et al, 1998;
Baumann et al, 2007; Li et al, 2007). PrPDHD is complex
glycosylated and linked to the plasma membrane through a
glycosylphosphatidylinositol (GPI) anchor (Winklhofer et al,
2003b), indicating that this neurotoxic mutant is at the same
cellular locale as PrPC. Indeed, results from different mouse
models were interpreted in such a way that neurotoxicity of
PrPDHD is linked to a PrPC-dependent signalling pathway
(Shmerling et al, 1998; Baumann et al, 2007; Li et al, 2007).
In contrast to the toxic activity of pathological PrP con-
formers appears to be the physiological function of PrPC. First
hints about the activity of PrPC to confer enhanced tolerance
to stress emerged from experiments with primary neurons
(Kuwahara et al, 1999). Using stroke models in rats and mice,
it was then demonstrated that PrPC has a neuroprotective
activity after an ischaemic insult (McLennan et al, 2004; Shyu
et al, 2005; Spudich et al, 2005; Weise et al, 2006; Mitteregger
et al, 2007). These findings in transgenic animals were
complemented and corroborated by several studies in cul-
tured cells supporting the idea that PrPC can modulate
signalling cascades, in particular stress-protective pathways
(Westergard et al, 2007).
We now show that stress-protective signalling of PrPC is
dependent on the internal HD and the C-terminal GPI anchor.
Furthermore, our data provide evidence for a switch from
antiapoptotic to pro-apoptotic signalling of PrPC induced by
neurotoxic PrP mutations and scrapie prions.
Results
The stress-protective activity of PrPC is dependent on
the GPI anchor and the internal HD
From previous studies in transgenic mice and cultured cells,
it emerged that expression of PrPC can confer enhanced stress
tolerance. As a cell culture system to analyse this activity, we
employed transiently transfected SH-SY5Y cells, which are
characterized by extremely low levels of endogenous PrPC
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(Rambold et al, 2006). Cells were exposed to the excitotoxin
kainate and apoptotic cell death was determined by the
detection of activated caspase-3. Ectopic expression of wild-
type (wt) PrP, but not PrPDN, significantly enhanced survival
of cells exposed to kainate (Figure 1B), corroborating results
obtained in mice models (Mitteregger et al, 2007).
To identify additional domains of PrPC essential for the
stress-protective activity, a variety of PrP mutants were ana-
lysed (Figure 1A). It turned out that PrP needs to be attached to
the plasma membrane through a GPI anchor: PrP-CD4, which
contains a heterologous C-terminal transmembrane domain
instead of the GPI anchor (Taraboulos et al, 1995; Winklhofer
et al, 2003b), showed no antiapoptotic activity (Figure 1B).
The stress-protective activity was also lost when the short
internal HD (amino acids 113–133) was deleted (Figure 1B).
Moreover, deletion of the HD induces a switch from antiapop-
totic to pro-apoptotic signalling. Apoptotic cell death was
significantly increased in cells expressing PrPDHD (Figure 1B
and C). In line with the protective activity of PrPC against
PrPDHD-induced toxicity in transgenic animals, co-expression
of wt PrP alleviated the pro-apoptotic activity of PrPDHD in
SH-SY5Y cells (Figure 1C).
Notably, deletion of the HD or the N terminus seems not to
interfere with maturation and cellular trafficking of PrP.
Similarly to wt PrP, PrPDHD and PrPDN are complex glyco-
sylated and targeted to detergent-insoluble microdomains at
the plasma membrane (Figure 1D) (Winklhofer et al, 2003b).
PrP-CD4 is also complex glycosylated and present at the
plasma membrane, but does not localize to detergent-inso-
luble microdomains (Figure 1D).
The HD mediates dimer formation of PrPC
After having shown that the HD is required for the stress-
protective activity of PrPC, we sought to analyse the role of
the HD in mediating this effect. Signalling by cell surface
proteins is often linked to dimer formation, and PrP dimers
were reported in previous publications (Priola et al, 1995;
Meyer et al, 2000), with the HD as a putative dimerization
domain (Warwicker, 2000).
To examine dimer formation of endogenous PrPC in N2a
cells, we released PrPC from the plasma membrane through
digestion with phosphatidylinositol phospholipase C (PIPLC).
The cell culture supernatant was collected and separated by
native PAGE. Western blotting revealed two separate bands of
endogenous PrPC (Figure 2A, endogenous PrPC). Ectopically
expressed wt PrP showed a migration pattern similar to that
of endogenous PrPC (Figure 2A, transfected PrP). To provide
more evidence that the slower migrating PrPC species might
be a dimer, we replaced serine 131 by cysteine (PrP-S131C).
If HD is part of the dimer interface, C131 could form an
intermolecular disulphide bond, which would be stable under
non-reducing conditions. First, we analysed ectopically ex-
pressed wt PrP, PrP-S131C and PrPDHD by native PAGE. This
analysis provided a first clue that the HD is necessary for PrP
dimerization; in PrPDHD-expressing cells only the faster
migrating band was detectable, whereas PrP-S131C seemed
to stabilize dimer formation (Figure 2B). Next, the super-
natants of PIPLC-treated transfected cells were analysed by
SDS–PAGE. Under non-reducing conditions, an additional
slower migrating band was detectable for PrP-S131C, which
disappeared under reducing conditions (Figure 2C). These
approaches revealed that (i) endogenous PrPC can form a
dimer, (ii) the HD is part of the dimer interface and (iii) the
PrP dimer is present at the plasma membrane. Disulphide-
linked dimers of PrP-S131C could also be detected in total cell
lysates (Figure 2D) and in detergent-resistant membranes
Figure 1 The internal hydrophobic domain and the GPI anchor are
necessary for the protective activity of PrPC. (A) Schematic pre-
sentation of the PrP mutants analysed. ER-SS: ER signal sequence;
OR: octarepeat; HD: hydrophobic domain; a: a-helical region; b:
b-strand; GPI-SS: GPI signal sequence; CD4-TM: transmembrane
domain of CD4. (B) wt PrPC protects against stress-induced apop-
tosis. SH-SY5Y cells expressing the constructs indicated were
stressed with kainic acid (500mM) at 371C for 3 h, fixed, permeabi-
lized, and activation of caspase-3 was analysed by indirect immu-
nofluorescence. In total, 300 transfected cells in at least three
independent experiments were counted. The percentage of apopto-
tic cells among transfected cells is shown. Expression levels were
analysed by immunoblotting (right panel). Lane DN was positioned
to the right side of the gel, all lanes originate from one gel.
(C) Expression of wt PrP interferes with toxic effects of PrPDHD.
SH-SY5Y cells were transiently transfected with PrPDHD or PrPDHD
and wt PrP. Apoptotic cell death was determined as described under
(B). Expression levels were analysed by immunoblotting (right
panel). (D) Wt PrP, PrPDHD, DN and CD4 localize to detergent-
insoluble microdomains. N2a cells were transiently transfected with
the constructs indicated, lysed in ice-cold buffer C and fractionated
by a discontinuous sucrose gradient. PrP was detected by immuno-
blotting using the mAb 3F4. **Po0.005.
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(Supplementary Figure 1). As a third approach to analyse
dimer formation, we performed crosslinking experiments.
Indeed, a PrP crosslink at a size indicative of a PrP dimer
was observed for wt PrP in cultured cells and mouse brain,
whereas crosslinking of PrPDHD did not result in such a
higher molecular weight species (Figure 2E and F).
To provide further support for the assumption that dimer
formation is linked to the stress-protective activity of PrP, we
introduced the S131C substitution in those PrP mutants that
did not confer enhanced stress tolerance, namely PrPDHD,
PrPDN and PrP-CD4. Please note that for the construction
of DHD-S131C the HD deletion was limited to amino acids
112–128. DHD-S131C and CD4-S131C showed significantly
reduced dimer formation in comparison to PrP-S131C
(Figure 3A and B). Interestingly, DN showed dimer formation
but no neuroprotective activity, suggesting that dimer forma-
tion might be necessary but not sufficient for the neuroprotec-
tive activity of PrP. Supporting the notion that dimerization of
PrP might be linked to its stress-protective activity, dimerization
of PrP-S131C was increased after stress treatment (Figure 3C).
To follow up the question whether PrP dimer formation is
associated with stress-protective signalling of PrPC, we used
different anti-PrP antibodies to induce PrP dimerization at the
plasma membrane. Treatment of cell expressing wt PrP with
the antibodies 3F4 and SAF61, which bind adjacent to the HD,
induced phosphorylation of ERK, whereas 4H11, which binds
directly to the HD, did not (Figure 3D). Moreover, antibody
treatment did not induce ERK signalling in cells expressing
PrPDN or PrP-CD4, mutants devoid of a stress-protective
activity (Figure 1).
In summary, our data revealed that dimers of PrPC are
present at the plasma membrane of neuronal cells. Dimer
formation as well as the stress-protective activity of PrPC is
dependent on the internal HD and the C-terminal GPI anchor.
Scrapie-infected cells are more sensitive to stress
and are impaired in PrPC dimerization
ScN2a cells are chronically scrapie-infected N2a cells that
propagate PrPSc and infectious prions (Butler et al, 1988;
Caughey and Raymond, 1991; Borchelt et al, 1992). In con-
trast to the uninfected N2a cells, ScN2a cells accumulate
significant amounts of detergent-insoluble and protease
K-resistant PrPSc (Figure 4A). When we compared the
proliferation rates of ScN2a cells with that of uninfected
Figure 2 The internal hydrophobic domain promotes homo-dimerization of PrP. (A) PrPC forms dimers. Live N2a cells either untransfected or
transiently expressing wt PrP were incubated for 2 h with PIPLC in PBS at 371C. Proteins present in the cell culture supernatant were analysed
by native PAGE using the anti-PrP antiserum A7 (endogenous PrPC) or the mAb 3F4 (transfected). Western blot membrane was divided for
treatment with the specific antibodies indicated, as indicated by a white line. All samples originate form one gel. (B–F) Dimerization of PrP is
dependent on the HD. (B, C) Transiently transfected SH-SY5Y cells were incubated for 2 h with PIPLC in PBS at 371C and proteins in the cell
culture supernatant were analysed by (B) native PAGE or (C) SDS–PAGE under reducing (þb-ME) or non-reducing (b-ME) conditions. PrP
was detected by western blotting using the mAb 3F4. (D) Total cell lysates of transiently transfected SH-SY5Y cells were analysed as described
under (C). (E, F) Crude membranes from SH-SY5Y cells, Tg20 or wt mouse brains were incubated for 1 h at 41C with increasing concentrations
of the chemical crosslinker DTSSP. PrP was detected by immunoblotting using the mAb 3F4. Closed arrowheads indicate dimeric forms of PrP,
open arrowheads indicate PrP monomers.
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N2a cells, it appeared that PrPSc propagation does not sig-
nificantly interfere with cell viability (Figure 4B), corroborat-
ing earlier results (Bosque and Prusiner, 2000). This picture
completely changed, when we analysed cell viability after
stress. We subjected N2a and ScN2a cells to heat or oxidative
stress and determined cell survival after 24 h. In both stress
paradigms, ScN2a cells were significantly more sensitive
(Figure 4C and D). In ScN2a cells, the steady-state level of
PrPC, present in the detergent-soluble fraction, was at least as
high as in N2a cells, suggesting that reduced level of PrPC does
not account for the differences in vulnerability to stress
(Figure 4A). Next, we analysed PrP-S131C dimer formation
in N2a and ScN2a cells at day 2 and 5 after plating. The
rationale behind this strategy was the observation that the
relative amount of PrPSc increases over time (Figure 4F).
Transfection efficiency was decreased in 5-day-old cells; how-
ever, the monomer to dimer ratio was unchanged in N2a cells.
In contrast, the relative amount of PrP-S131C dimers nega-
tively correlated with the PrPSc load: ScN2a cells harbouring
less PrPSc had more dimers compared with cells that had
accumulated larger amounts of PrPSc (Figure 4E and F). To
test whether dimeric PrP is a substrate for the formation of
PrPSc, we transfected ScN2a cells and analysed the conversion
of the constructs into proteinase K (PK)-resistant PrP. PrPDHD
was not converted, corroborating earlier results (Holscher
et al, 1998). Interestingly, PrP-S131C was also less efficiently
converted into PrPSc, suggesting that a PrPC dimer is not an
optimal substrate for PrPSc propagation (Figure 4G).
In summary, our experiments revealed that scrapie-
infected N2a cells are significantly more vulnerable to stress
and that the accumulation of PrPSc interferes with PrP dimer
formation.
Pro-apoptotic signalling of scrapie prions through PrPC
A major question in prion diseases and other neurodegen-
erative disorders is how misfolded protein conformers induce
Figure 3 Dimerization of PrP induces intracellular signalling and is dependent on the hydrophobic domain and the GPI anchor.
(A) Dimerization of PrP is dependent on the hydrophobic domain and the GPI anchor. Wt PrP-S131C, DHD-S131C, DN-S131C or CD4-S131C
was expressed in SH-SY5Y cells and PrP dimers present in total cell lysates were analysed by SDS–PAGE/western blotting under non-reducing
conditions. (B) Quantification of PrP dimer formation. The ratio of dimeric to monomeric PrP, analysed in at least three independent
experiments, is shown. (C) Stress-induced dimerization of PrP. SH-SY5Y cells were transfected with S131C or GFP–GPI, incubated with kainate
(250 mM) for 2 h at 371C. PrP and GFP–GPI was detected by western blotting using the mAb 3F4 and the anti-GFP antibody, respectively.
(D) Antibody-induced signalling of PrP is dependent on the N terminus, the HD and the GPI anchor. SH-SY5Y cells were transfected with wt
PrP, PrPDN or PrPCD4 as indicated. Cells were incubated for 10min with increasing concentrations of the antibodies 3F4, 4H11 or SAF61, as
indicated. P-ERK and ERK were visualized by immunoblotting. Loading was controlled by re-probing the blots for actin. *Po0.05.
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neuronal cell death. In prion diseases, neurodegeneration is
dependent on the expression of GPI-anchored PrPC in neuro-
nal cells (Brandner et al, 1996; Mallucci et al, 2003; Chesebro
et al, 2005). One possible explanation for this phenomenon is
that PrPC-dependent pathways mediate toxic signalling of
PrPSc or prions. To analyse this possibility in more detail,
we developed a novel assay based on the co-cultivation of
uninfected cells with persistently infected ScN2a cells. The
rationale of this approach was the observation that PrPSc
is actively released into the extracellular environment by
PrP-expressing cells (Fevrier et al, 2004; Vella et al, 2007).
SH-SY5Y cells grown on cover slips were transiently trans-
fected with wt PrP, or mutants lacking a stress-protective
activity. A cover slip was then placed into a cell culture dish
with N2a or ScN2a cells and apoptosis of SH-SY5Y cells was
analysed after 16 h in co-culture (Figure 5A). Control-trans-
fected SH-SY5Y cells expressing GPI-anchored GFP could be
co-cultivated with N2a or ScN2a cells without adverse effects
on cell viability (Figure 5B; GFP–GPI). Similarly, SH-SY5Y
cells expressing wt PrP did not undergo apoptosis when co-
cultured with uninfected N2a cells. However, a significant
increase in apoptotic cell death was observed when SH-SY5Y
Figure 4 Scrapie prion propagating N2a cells are more susceptible to stress and contain reduced levels of PrPC dimers. (A) ScN2a cells
accumulate detergent-insoluble and proteinase K (PK)-resistant PrP. N2a and ScN2a cells were grown for 5 days until confluency. Cells were
lysed and PrP present in the detergent-soluble (S) and -insoluble (P) fraction or after a limited PK digest (right panel) was detected by western
blotting using the anti-PrP antiserum A7. (B–D) Impaired viability of ScN2a cells after stress. (B) Equal number of cells was seeded onto cell
culture dishes and cell numbers were determined by counting on 5 consecutive days. (C, D) N2a and ScN2a cells were grown for 4 days and
treated with (C) increasing concentrations of H2O2 for 30min or (D) subjected to a heat shock at 461C for the times indicated. After 24 h cells
were counted. Cell death was visualized using Trypan blue. (E, F) Increased PrPSc load is paralleled by a decrease in PrP dimerization. N2a and
ScN2a cells were transfected with wt PrP or PrP-S131C 1 or 4 days after plating. After additional 24 h (days 2 and 5, respectively) cells were
scraped off the plate and lysed. (E) Lysates were analysed in toto by SDS–PAGE under non-reducing conditions. PrP was detected using the
mAb 3F4. The ratio of dimeric/monomeric PrP was quantified from at least three independent experiments (lower graph). Closed arrowheads
indicate dimeric forms of PrP, open arrowheads indicate PrP monomers. (F) Mock-transfected dishes of ScN2a cells (2 and 5 day old) were
lysed and treated with PK prior to western blotting. The relative amount of PK-resistant PrPSc was quantified from at least three independent
experiments (lower graph). (G) Dimeric PrP cannot be converted to PrPSc. ScN2a cells were transfected with wt PrP, S131C, PrPDHD or GFP–
GPI and grown for 4 days. Cell lysates were treated with PK and remaining PrP was detected by western blot using the mAb 3F4. PK resistance
is highlighted by a black frame. *Po0.05.
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cells expressing wt PrP were co-cultivated with ScN2a cells
(Figure 5B; wt). As described above, expression of PrPDHD
was toxic to SH-SY5Y cells; however, co-cultivation with
ScN2a cells did not increase apoptotic cell death in
PrPDHD-expressing SH-SY5Y cells (Figure 5B; DHD).
Moreover, PrP-CD4, a mutant defective in stress-protective
signalling and dimerization, did not sensitize SH-SY5Y cells
to PrPSc-induced apoptosis (Figure 5B; CD4).
To provide support for the assumption that the inducer of
toxicity is PrPSc, we co-cultivated wt PrP-expressing SH-SY5Y
cells with ScN2a cells ‘cured’ of PrPSc. We have previously
shown that incubation with DOSPA, a cationic lipopolyamine,
efficiently reduced the levels of PrPSc in ScN2a cells
(Winklhofer and Tatzelt, 2000). In contrast to untreated
ScN2a cells, DOSPA-treated ScN2a cells, which are character-
ized by a significantly reduced amount of PrPSc, did not
induce apoptosis in PrP-expressing SH-SY5Y cells
(Figure 5C).
Thus, our cell culture co-cultivation assay revealed that
scrapie-infected cells can induce apoptotic cell death in trans.
This toxic signalling was dependent on the propagation of
PrPSc in ScN2a cells and the expression of GPI-anchored wt
PrP in co-cultured cells.
Scrapie-induced apoptosis in PrPC-expressing cells is
linked to the activation of the Jun N-terminal kinase and
can be blocked by Jun N-terminal kinase inhibitors
The experiments described above provided evidence for an
apoptotic process in wt PrP-expressing SH-SY5Y cells when
co-cultivated with ScN2a cells. To get insight into the intra-
cellular pathways involved, we analysed key components of
apoptotic signalling cascades. We observed phosphorylation
of Jun N-terminal kinase (JNK) specifically in wt PrP-expres-
sing SH-SY5Y cells upon co-cultivation with ScN2a cells
(Figure 6A, left panel). We did not see consistent activation
of ERK or p38 under these conditions, although ERK seems to
become slightly activated when co-cultured with ScN2a cells
(Figure 6A, middle and right panels). To test whether activa-
tion of JNK is linked to the apoptotic cell death of PrP-
expressing SH-SY5Y cells, the JNK inhibitor II was added.
Figure 5 Scrapie prions induce apoptosis in PrPC-expressing cells. (A) Schematic model of the co-cultivation assay. SH-SY5Y cells were grown
on cover slips and transfected. At 3 h after transfection, cover slips were transferred to a cell culture dish with N2a or ScN2a cells and co-
cultivated for 16 h. (B) Scrapie-infected cells induce apoptosis in wt PrP-expressing cells. SH-SY5Y cells were transiently transfected with the
constructs indicated and co-cultivated with N2a or ScN2a cells for 16 h. Cells were fixed and stained for activated caspase-3. Apoptotic cells
among the transfected were counted in at least three independent experiments. The percentage of apoptotic cells is shown. ***Po0.0005;
*Po0.05. Expression of PrP in the SH-SY5Y cells co-cultivated with N2a or ScN2a cells was analysed by immunoblotting using the mAb 3F4.
Lower panel: SH-SY5Y cells were transiently transfected with GFP–GPI or wt PrP and co-cultivated with ScN2a or DOSPA-treated ScN2a cells.
Apoptotic cell death in the SH-SY5Y cells was determined as described under (B). The western blot image was re-arranged by positioning lane
DN to the right end of the blot, as indicated by a white line. All samples originate from one gel. (C) Parallel dishes of ScN2a and DOSPA-treated
ScN2a cells were lysed and PrP present in the detergent-soluble (S) and -insoluble (P) fractions was analysed by western blotting using the anti-
PrP antiserum A7 (lower panel). Actin analysed in whole lysates (WL).
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Indeed, cell death in PrP-expressing SH-SY5Y co-cultured
with ScN2a cells was significantly reduced in the presence
of the JNK inhibitor (Figure 6B). A similar reduction in
apoptotic cell death was achieved by co-expressing the anti-
apoptotic protein Bcl-2. The functionality of the JNK inhibitor
was verified in cells exposed to anisomycin (data not shown).
Discussion
Stress-protective signalling of PrP: a prominent role
for the internal HD
In our study, we analysed various PrP mutants to define
determinants of the neuroprotective activity of PrPC. First, we
showed that expression of wt PrP conferred enhanced stress
tolerance to cells, whereas deletion of the unstructured
N terminus abolished this activity, corroborating previous
findings in mice. Next, we identified two novel domains
linked to the stress-protective activity of PrP: the internal
HD and the C-terminal GPI anchor. PrP-CD4, a mutant with a
transmembrane domain instead of a GPI anchor, is complex
glycosylated and present at the outer leaflet of the plasma
membrane; however, PrPCD4 is not targeted to detergent-
insoluble microdomains. Possibly, PrP-CD4 cannot interact
with a, yet unidentified, transmembrane protein necessary to
induce signal transduction. The GPI anchor might provide a
higher degree of structural flexibility favouring intermolecu-
lar interactions at the plasma membrane, or targeting of PrP
to detergent-insoluble microdomains is a prerequisite for
such an interaction.
Our study reinforces the prominent role of the internal HD
in stress-protective signalling of PrP. Expression of PrPDHD
can lead to apoptotic cell death and co-expression of wt PrPC
interferes with pro-apoptotic signalling of PrPDHD. Our func-
tional characterization of the HD allows the conclusion that
the stress-protective signalling of wt PrPC is linked to dimer
formation with the HD as part of the dimer interface. The
analysis of PrPC in cultured cells and mouse brain by native
PAGE and crosslinking approaches provided experimental
evidence that wt PrP can form homo-dimers and that deletion
of the HD interferes with dimer formation. Further evidence
was obtained by introducing a cysteine into the HD (PrP-
S131C). Such an approach was successfully used to identify
the dimerization domain of the transmembrane receptor
ErbB-2/Her2 (Cao et al, 1992) and the amyloid precursor
protein (Munter et al, 2007). Similarly to wt PrP, the PrP-
S131C dimer was complex glycosylated, present at the plasma
membrane in detergent-insoluble microdomains (rafts) and
could be liberated by PIPLC digestion. Previous in vitro
studies indicated that native PrPC purified from bovine
brain exists as a monomer–dimer equilibrium, but not re-
combinant PrP, suggesting that post-translational modifica-
tions might be implicated in dimer formation (Meyer et al,
2000). This is in line with our observation that the GPI anchor
is necessary for dimer formation. The formation of PrP
dimers upon overexpression of hamster PrP in mouse cells
was previously described (Priola et al, 1995), which seem to
be different from the PrP dimers we describe in our study.
Notably, the dimers we describe rapidly dissociate in the
presence of SDS, are formed in a post-Golgi compartment and
are complex glycosylated (Supplementary Figure 1).
On the basis of our data presented above and available
NMR analysis (Riek et al, 1998; Liu et al, 1999), we built
models of a PrPC dimer present at the cell surface (Figure 7).
The dimer models were created by docking two identical PrP
monomers with cysteines introduced at position 131, and
looking for docking configurations, where the two opposing
cysteines were positioned at a disulphide bridge distance.
Figure 7 depicts two configurations, one, where both
Figure 6 Scrapie prions activate JNK only in wt PrP-expressing cells. (A) Co-cultivation with ScN2a cells activates JNK in wt PrP-expressing
cells. SH-SY5Y cells were transfected with wt PrP or GFP–GPI and co-cultivated for 16 h with N2a or ScN2a cells. Cells were lysed, and
phosphorylated and non-phosphorylated forms of JNK, ERK and p38 were analysed by western blotting. Blots were re-probed for actin to
control for equal loading. (B) JNK inhibitors interfere with scrapie prion-induced apoptosis. Cells were transfected with GFP–GPI or wt PrP and
incubated with the JNK inhibitor II (for 16 h, 1 mM) or co-transfected with Bcl-2. Cells were co-cultivated for 16 h with ScN2a cells, fixed and
stained for activated caspase-3. Apoptotic cells were counted and the percentage of apoptotic to transfected cells was evaluated, *Po0.05,
**Po0.005.
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monomers were attached to the same cell (Figure 7A), and
the other configuration where the monomers were attached
to adjacent cells (Figure 7B).
Different lines of evidence support the scenario that dimer
formation of PrPC is essential for its neuroprotective activity.
First, two PrP mutants impaired in dimer formation, PrPDHD
and PrP-CD4, did not protect cells from stress-induced cell
death. Second, stress treatment induced PrP dimerization.
Third, scrapie prions interfere with dimer formation and the
stress-protective activity of PrPC. However, dimer formation
of PrPC seems to be required but not sufficient for its stress-
protective activity: a PrP mutant lacking the unstructured
N-terminal domain does not confer enhanced stress tolerance
to cells. Cellular targeting and dimerization of PrPDN is not
impaired, but the N-terminal domain might be required for a
productive interaction of PrP with its putative co-receptor or
for endocytosis of the signalling complex.
Toxic signalling of scrapie prions in PrPC-expressing
cells
Grafting experiments provided the first evidence that PrPSc is
not toxic to neurons devoid of PrPC (Brandner et al, 1996),
which was corroborated by additional studies (Mallucci et al,
2003; Chesebro et al, 2005). On the basis of these animal
models, two plausible scenarios for the toxic effects of PrPSc
can be envisaged. Either, neurotoxicity of PrPSc is linked to its
propagation in neuronal cells, which is dependent on the
expression of PrPC, or PrPSc elicits a deadly signal through a
PrPC-dependent signalling pathway. Please note that we are
using PrPSc as provisional term for a pathological conformer
of PrP with neurotoxic activity. Whether this is a PK-resistant
intermediate generated during the conversion process or an
oligomer or fibril is unclear at the moment. Similarly, it might
well be that the neurotoxic and the infectious PrP conformers
are distinct species. Indeed, the existence of discrete confor-
mers would explain the phenomenon of subclinical prion
infection (Hill et al, 2000).
We developed a new co-cultivation assay based on the fact
that PrPSc is actively released into the extracellular environ-
ment through exosomes from scrapie-infected cells (Fevrier
et al, 2004; Vella et al, 2007). This allowed us to study the
toxic effects of prion replication mechanistically. Co-cultiva-
tion with ScN2a cells induced apoptosis in SH-SY5Y cells, but
only when the latter transiently expressed wt PrP. N2a or
ScN2a cells cured of PrPSc did not induce apoptosis, indicat-
ing that the apoptotic effect was dependent on the presence of
PrPSc. Scrapie prion-induced cell death was paralleled by the
activation of JNK in SH-SY5Y cells, and the addition of a JNK
inhibitor to the co-cultivation medium significantly reduced
apoptotic cell death in SH-SY5Y cells, providing a causal link
between JNK activation and PrPSc-induced apoptosis. This is
in line with the observation that JNK is activated in the brains
of scrapie-infected mice and hamsters (Carimalo et al, 2005;
Lee et al, 2005).
Figure 7 Putative model structures of a PrPC dimmer. (A) Both monomers attached to the same cell. (B) ‘Trans’ dimer: monomers attached to
neighbouring cells. The PrP dimers appear in cartoon representation, with the side chains of the cysteine residues in sphere representation; the
Asn181 and Asn197-linked N-glycans and the GPI anchors appear in stick representations, whereas the membrane is a schematic drawing.
Colouring scheme: the two monomers are in red and blue; the glycans and GPI anchor attached to the red monomer are coloured in red shades,
and the ones attached to the blue monomer appear in blue shades, respectively. (C) A model for the stress-protective signalling of PrPC under
physiological conditions and pro-apoptotic signalling induced by PrPSc. PrPC: green circle; PrPSc: red square; toxic conformer: green diamond;
putative PrP receptor: grey. The model suggests the following scenario: (1) PrPC dimerizes and can induce protective signalling through
a putative transmembrane receptor (either in trans or in cis). (2) Interaction of PrPC with PrPSc is leading to a pathogenic PrP complex, which
is still able to interact with the putative PrPC receptor; however, the interaction leads to an aberrant, toxic signalling.
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Remarkably, our co-cultivation approach revealed that
neurotoxic signalling induced by scrapie prions was depen-
dent on a physiologically active PrPC (Table I). Expression of
PrP mutants impaired in their stress-protective potential,
such as PrPDN or PrP-CD4, did not sensitize SH-SY5Y cells
to PrPSc-induced toxicity. In line with this observation,
PrPDHD expression was toxic per se; however, PrPSc did not
increase the toxicity of PrPDHD. How can our data be brought
together to explain the PrPC-dependent effects of PrPSc? PrPSc
could modulate the interaction of PrPC with its putative co-
receptor, possibly due to the formation of a PrPC/PrPSc
complex. As a consequence, there is a switch from a stress-
protective to a pro-apoptotic signalling, possibly due to over-
stimulation of the receptor (Figure 7C). Indeed, pro-apoptotic
signalling by PrPC can be induced in vivo by antibody-
induced crosslinking (Solforosi et al, 2004). Compatible
with the model of a common receptor for both apoptotic
and antiapoptotic signalling is the toxic potential of PrPDHD.
As suggested previously (Baumann et al, 2007; Li et al, 2007),
deletion of the HD might alter the conformation of PrP and
thereby the interaction with the PrPC co-receptor, resulting in
toxic signalling.
We have now to await the identification of the signalling
complex(es) to provide further experimental evidence for
such pathways. A better understanding of the auxiliary
components implicated in the physiological activity of PrPC
and neurotoxic signalling of pathogenic PrP mutants will not
only enhance our understanding of stress-induced signalling
cascades in neuronal cells but might also allow to develop
novel strategies for the treatment of prion diseases.
Materials and methods
Antibodies and reagents
The following antibodies were used: anti-PrP 3F4 monoclonal
antibody (mAb; Kascsak et al, 1987), anti-PrP antiserum A7
(Winklhofer et al, 2003a), anti-active caspase-3 polyclonal antibody
(Promega), anti-FLAG M2 mouse mAb (Sigma), Cy3-conjugated
anti-rabbit IgG antibody (Dianova), anti-phospho-SAPK/JNK, anti-
phospho-p38, anti-phospho-p42/44, anti-JNK, anti-p38 and anti-
ERK (Cell Signaling). The following reagents were used: kainic acid
(Calbiochem), JNK inhibitor II (Calbiochem), endoglycosidase H
(endoH; Calbiochem), peptide N-glycosidase F (PNGaseF; Calbio-
chem), proteinase-K (PK; Sigma), Brefeldin A (Sigma), 3,30-
dithiobis[sulphosuccinimidylpropionate] (DTSSP; Pierce). The
mounting medium Mowiol (Calbiochem) was supplemented with
40,6-diamidino-2-phenylindole (DAPI; Sigma).
Plasmids
The following constructs were described previously: wt PrP, PrP-
CD4, T183A (Winklhofer et al, 2003b; Kiachopoulos et al, 2005) and
FLAG–Bcl-2 (Rambold et al, 2006). All amino-acid numbers refer to
the mouse PrP sequence (GenBankTM accession number NP
035300) or to human Bcl-2 sequence (GenBankTMaccession number
AAA51813). In PrPDHD, the amino acids 113–133 were deleted. For
the generation of PrP-S131C a serine at position 131 was exchanged
to a cysteine. In PrPDHD-S131C, the amino acids 112–128 were
deleted. As transfection marker the EYFP-C1 vector (Clontech) was
used.
Cell culture, co-cultivation and curing experiments
Cells were cultivated and transfected as described earlier (Winkl-
hofer and Tatzelt, 2000; Winklhofer et al, 2003b). For co-cultivation
experiments, SH-SY5Y cells were grown on glass cover slips and
transfected with LipofectAMINE Plus reagent. At 3 h after transfec-
tion, cover slips were transferred into dishes containing a 90%
confluent cell layer of either N2a or ScN2a cells. After 16 h in co-
culture, apoptotic cell death in SH-SY5Y cells was analysed (see
below). ScN2a cells were cured of PrPSc by treatment with DOSPA
(Winklhofer and Tatzelt, 2000).
Cell lysis, detergent solubility assay, western blotting
and sucrose step gradient
As described earlier (Tatzelt et al, 1996), cells were washed twice
with cold PBS, scraped off the plate and lysed in cold buffer A
(0.5% Triton X-100, 0.5% sodium deoxycholate in PBS). The lysates
were either analysed directly or centrifuged to generate detergent-
soluble (S) and -insoluble (P) fractions. SDS–PAGE and western
blotting was described earlier (Winklhofer and Tatzelt, 2000). For
the detection of phosphorylated proteins, cells were lysed in cold
buffer B (20mM Tris (pH 7.5), 150mM NaCl, 1mM EDTA, 1mM
EGTA, 1% Triton X-100, 2.5mM sodium pyrophosphate, 1mM b-
glycerophosphate, 1mM Na3Vo4 and 1mg/ml leupeptin), centri-
fuged for 10min at 13 000 r.p.m. and the postnuclear supernatant
was analysed by western blotting according to the manufacturer’s
instruction. For the sucrose step, gradient cells were harvested and
resuspended in 200ml buffer C (25mM MES, 150mM NaCl, pH 6.5)
containing 1% Triton X-100 and homogenized by passing 15 times
through a Luer 21-gauge needle. After centrifugation at 500 g for
5min, the supernatant was made up to 40% sucrose by adding an
equal volume of 80% sucrose in buffer C. The sample was placed
beneath a discontinuous gradient of sucrose consisting of 3ml of
30% sucrose and 1ml of 5% sucrose, both in buffer C. The samples
were then centrifuged at 140 000 g in a SW-55 rotor (Beckman
Coulter) for 18 h at 41C. The sucrose gradient was harvested in
0.5ml fractions from the top of the gradient, precipitated by TCA
and analysed by western blotting.
Chemical crosslinking
Transfected N2a, SH-SY5Y cells or total mouse brain were lysed by
addition of 150 ml or 1ml of crosslinking buffer (250mM sucrose,
5mM Hepes (pH 7,4), 1mM MgCl2 and 10mM KCl), respectively,
and passing 15 times through a Luer 21-gauge needle. After
centrifugation for 20min at 800 g, the supernatant was incubated
with the chemical crosslinker DTSSP for 1 h at 41C as specified by
the manufacturer, at the concentrations indicated. Proteins were
precipitated by TCA and analysed by western blotting.
Conversion assay
ScN2a cells were transfected with 2mg DNA and grown for 4 days
until total confluency. Cells were lysed in cold buffer A and
centrifuged for 1min at 1000 g. The supernatant was incubated with
10 mg/ml PK for 40min at 221C and the reaction was quenched by
Table I Characteristic features of the PrP constructs used in this study
PrP Cell surface DRM Stress protective Toxic PrPSc mediated Conversion into PrPSc
WT + + +  ++ ++
S131C + + +  +a 
DN + +   + +b
DHD + +  +  
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addition of 2mM PMSF. Residual proteins were precipitated by
TCA and transfected PrP was detected by western blotting using the
mAb 3F4.
Stress induction, phospholipase C and JNK inhibitor
treatment
Kainic acid was dissolved in water and added to the cell culture
medium. JNK inhibitor II was dissolved in water and cells were
incubated with 1 mM for 16 h at 371C during co-cultivation.
Phospholipase C treatment was described earlier (Winklhofer
et al, 2003b). Briefly, cells were washed twice with ice-cold PBS
and PIPLC in PBS was added to the cells for 3 h at 371C. Cell culture
supernatants were collected and proteins were precipitated by TCA.
Native PAGE
PrP-transfected SH-SY5Y cells were treated with PIPLC and proteins
in the cell culture supernatant were collected and concentrated by
centrifugation at 1000 g for 15min at 41C in Vivaspin tubes (excision
size: 30 000 MW; Vivascience). Sample buffer (6 ; 360mM Tris–
HCl (pH 6.8), 60% glycerol, 0.4% Coomassie blue brilliant
servablue) was added to the concentrated samples and the samples
were loaded on native gels. Native gels consisted of stacking gel
(4% acrylamid, 150mM Tris–HCl (pH 6.8), 0.1% TEMED, 0.1%
APS) and resolving gel (8% acrylamid, 375mM Tris–HCl (pH 8.8),
0.1% TEMED, 0.1% APS). Gel running was performed in gel
running buffer (25mM Tris and 189mM glycine) for 4 h with
increasing working voltage (80–180V). The proteins were trans-
ferred to a PVDF membrane (Millipore Immobilon) in blotting
buffer (20mM Tris, 150mM glycine and 20% methanol) for 60min
at 80V. The membrane was dried and extensively washed in
isopropanol, neutralized in H2O for 1min, washed with PBST for
10min and blocked with 5% milk in PBST.
Proliferation and cell survival measurements
Equal cell numbers of N2a and ScN2a cells were seeded. The
proliferation rate of both cell lines was determined by counting
trypsinated cells daily over a period of 5 days using a Neubauer-
counting chamber. For cell survival measurements, cells were
stressed 4 days after seeding with H2O2 for 30min, or subjected to a
461C heat shock. At 24 h after stress treatment, cells were
trypsinated and the number of live cells was determined by Trypan
blue exclusion assay.
Apoptosis assay
As described before (Rambold et al, 2006), SH-SY5Y cells were
grown on glass cover slips, fixed with 3% PFA for 20min and
permeabilized with 0.2% Triton X-100 in PBS for 10min at room
temperature. The primary antibody anti-active caspase-3 was
incubated for 45min at 371C in 1% BSA. After extensive washing
with cold PBS, incubation with the Cy3-conjugated secondary
antibody followed at 201C for 90min. Cells were mounted onto
glass slides and examined by fluorescence microscopy using a Zeiss
Axiovert 200M microscope (Carl Zeiss). The number of activated
caspase-3-positive cells out of 300 transfected cells was determined.
All quantifications were based on triplicates of at least three
independent experiments.
Generation of the PrP dimer model
The PrP dimer was built by docking two copies of the known
structure of a PrP monomer to each other. The monomer structure
used was the NMR structure of the mouse prion protein domain
mPrP (amino acids 121–231) solved by Wutrich’s group (pdb file:
1XYX) (Riek et al, 1998). A cysteine residue was introduced by
inserting a S131C substitution using the NEST homology modeling
package (Petrey et al, 2003), with default parameters. To create the
S-S-bonded dimer, two identical monomers were docked, using the
ZDOCK software (http://zlab.bu.edu/zdock) (Mintseris et al, 2005);
ZDOCK is a rigid-body docking software that searches for possible
binding configurations of the proteins, and evaluates them based on
shape complementarity, desolvation energy and electrostatics.
ZDOCK provides a series of putative docking configurations.
Docking was limited to configurations in which the contact between
the monomers involved the cysteines and their surroundings. The
resulting predicted structures were then filtered for configurations
in which the cysteines were at a distance of 6 Å or less. Thereafter,
the cysteines were bonded using the PyMol.
Statistical analysis
Data were expressed as means±s.e. All experiments were
performed in triplicates and repeated at least three times. Statistical
analysis among groups was performed using student’s t-test.
P-values are as follows: *Po0.05, **Po0.005 and ***Po0.0005.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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